Boron neutron capture therapy (BNCT) is a targeted radiotherapy that uses boron-10 as a delivery agent and neutrons as a source. BNCT selectively kills cancer cells by the high linear energy transfer of alpha particles and lithium ions produced during the nuclear reaction of boron-10 with neutrons. Clinical trials of BNCT have shown effectiveness in treating brain tumors and recurrent head and neck cancers. Further research is still needed to develop more effective boron delivery agents and neutron sources to advance this promising cancer treatment technique.